300511.SZ
雪榕生物
SZSE · A 农林牧渔 · CN
CNY 5.49
−2.14%Year over year
Reported trailing growth
- Revenue
- +11.3%
- EBITDA
- —
- EBIT
- +133.7%
- EPS
- +123.5%
- Free cash flow
- +25.7%
- Operating cash flow
- +20.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.0%
- EBITDA
- +64.9%
- EBIT
- +106.9%
- Net income
- +104.8%
- EPS
- +104.0%
- Free cash flow
- +91.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026